MedTrace Logo

Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)

NCT00185523 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2016-06-16

No results posted yet for this study

Summary

The purpose of the study is to evaluate the overall and disease free survival of recipients who have received G-CSF mobilized stem cells from HLA matched sibling donors.

Conditions

  • Leukemia, Lymphocytic, Acute
  • Leukemia
  • Leukemia Acute Promyelocytic Leukemia (APL)
  • Leukemia Acute Lymphoid Leukemia (ALL)
  • Leukemia Chronic Myelogenous Leukemia (CML)
  • Leukemia Acute Myeloid Leukemia (AML)
  • Leukemia Chronic Lymphocytic Leukemia (CLL)

Interventions

PROCEDURE

Allogeneic hematopoietic cell transplantation

Sponsors & Collaborators

Principal Investigators

  • Ginna Laport · Stanford University

Eligibility

Min Age
4 Weeks
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-05-31
Primary Completion
2009-04-30
Completion
2009-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00185523 on ClinicalTrials.gov